The US National Cancer Act of 1971 designated the director of the National Cancer Institute as responsible for coordinating federal agencies and nonfederal organizations to make progress against cancer. As part of her role, the immediate past director of the National Cancer Institute (MMB) led the development of a National Cancer Plan that was formally released on April 3, 2023. The plan includes 8 aspirational goals “to achieve a society where every person with cancer lives a full and active life and to prevent most cancers so that few people need to face this diagnosis.” Research findings provide a foundation for each goal, and research gaps are included in the strategies for meeting each goal. The President’s Cancer Panel, also created by the National Cancer Act, conducted an initial assessment of progress toward the plan goals by hearing from 12 organizations at a virtual public meeting on September 7, 2023. The purpose of this commentary is to orient the scientific community to the plan and call attention to related knowledge gaps that could benefit from research.

中文翻译：

---

研究界美国国家癌症计划简介

1971 年美国国家癌症法案指定国家癌症研究所所长负责协调联邦机构和非联邦组织在癌症防治方面取得进展。作为其职责的一部分，前任国家癌症研究所 (MMB) 所长领导制定了一项国家癌症计划，并于 2023 年 4 月 3 日正式发布。该计划包括 8 个理想目标“实现一个每个人都享有健康的社会”患有癌症的人可以过上充实而积极的生活，并预防大多数癌症，这样就很少有人需要面对这种诊断。” 研究结果为每个目标提供了基础，而研究差距则包含在实现每个目标的策略中。同样根据《国家癌症法案》成立的总统癌症小组在 2023 年 9 月 7 日的虚拟公开会议上听取了 12 个组织的意见，对计划目标的进展情况进行了初步评估。本评论的目的是为科学界提供指导计划并提请注意可从研究中受益的相关知识差距。